Edition:
United Kingdom

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.85USD
15 Feb 2019
Change (% chg)

$-0.11 (-5.61%)
Prev Close
$1.96
Open
$1.93
Day's High
$1.93
Day's Low
$1.85
Volume
2,541
Avg. Vol
6,152
52-wk High
$2.95
52-wk Low
$1.56

Chart for

About

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal... (more)

Overall

Beta: -8.40
Market Cap(Mil.): $71.13
Shares Outstanding(Mil.): 0.12
Dividend: --
Yield (%): --

Financials

  AKTX.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.84 -- --
ROI: -68.01 8.92 14.45
ROE: -68.13 10.08 15.96

Earnings vs. Estimates